Z-1440-2017Class II
Eclipse Hypodermic Needle
Becton Dickinson & Co / initiated 2016-12-20 / Terminated / root cause: design
Becton Dickinson & Company began a recall of Eclipse Hypodermic Needle on . FDA classified it as Class II and gives the reason as "BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries". As of , the recall status on record is Terminated, and MDM tags the root cause as design.
Recall record
- Recall number
- Z-1440-2017
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Becton Dickinson & Co
- Product
- Eclipse Hypodermic Needle
- Product code
- FMI Needle, Hypodermic, Single Lumen
- Reason for recall
- BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.
- Root cause tag
- design
- FDA root cause
- Device Design
- Action
- BD sent a Product Advisory Notice and Business Reply Card dated December 29, 2016 via UPS Ground delivery to their affected customers.
- Quantity in commerce
- 263 mm units
- Distribution
- US Nationwide
- Product codes and lots
- N/A
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1440-2017 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
